Your browser doesn't support javascript.
loading
Establishment of a Monoclonal Antibody against Human NTCP That Blocks Hepatitis B Virus Infection.
Takemori, Toshitada; Sugimoto-Ishige, Akiko; Nishitsuji, Hironori; Futamura, Yushi; Harada, Michishige; Kimura-Someya, Tomomi; Matsumoto, Takehisa; Honma, Teruki; Tanaka, Miho; Yaguchi, Masami; Isono, Kyoichi; Koseki, Haruhiko; Osada, Hiroyuki; Miki, Daiki; Saito, Takashi; Tanaka, Takashi; Fukami, Takehiro; Goto, Toshio; Shirouzu, Mikako; Shimotohno, Kunitada; Chayama, Kazuaki.
Afiliación
  • Takemori T; Drug Discovery Antibody Platform Unit, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Sugimoto-Ishige A; Laboratory for Inflammatory Regulation, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Nishitsuji H; Department of Clinical Laboratory, Tokyo Shinagawa Hospital, Tokyo, Japan.
  • Futamura Y; Drug Discovery Antibody Platform Unit, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Harada M; Laboratory for Inflammatory Regulation, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Kimura-Someya T; Department of Virology and Parasitology, Fujita Health University School of Medicine, Toyoake, Japan.
  • Matsumoto T; Chemical Biology Research Group, RIKEN Center for Sustainable Resource Science, Wako, Japan.
  • Honma T; Drug Discovery Antibody Platform Unit, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Tanaka M; Drug Discovery Structural Biology Platform Unit, RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan.
  • Yaguchi M; Drug Discovery Structural Biology Platform Unit, RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan.
  • Isono K; Drug Discovery Computational Chemistry Platform Unit, RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan.
  • Koseki H; Drug Discovery Antibody Platform Unit, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Osada H; Drug Discovery Antibody Platform Unit, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Miki D; Laboratory Animal Center, Wakayama Medical University, Wakayama, Japan.
  • Saito T; Laboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Tanaka T; Chemical Biology Research Group, RIKEN Center for Sustainable Resource Science, Wako, Japan.
  • Fukami T; Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima City, Japan.
  • Goto T; Research Center for Hepatology and Gastroenterology, Hiroshima University, Hiroshima City, Japan.
  • Shirouzu M; Drug Discovery Antibody Platform Unit, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Shimotohno K; Laboratory for Inflammatory Regulation, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Chayama K; RIKEN Program for Drug Discovery and Medical Technology Platforms, RIKEN Cluster for Science, Technology and Innovation Hub, Yokohama, Japan.
J Virol ; 96(5): e0168621, 2022 03 09.
Article en En | MEDLINE | ID: mdl-34985994
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Virus de la Hepatitis B / Transportadores de Anión Orgánico Sodio-Dependiente / Simportadores / Internalización del Virus / Hepatitis B Límite: Animals / Humans Idioma: En Revista: J Virol Año: 2022 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Virus de la Hepatitis B / Transportadores de Anión Orgánico Sodio-Dependiente / Simportadores / Internalización del Virus / Hepatitis B Límite: Animals / Humans Idioma: En Revista: J Virol Año: 2022 Tipo del documento: Article País de afiliación: Japón